COMPASS 3.1 / 3.1a 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 IBA Dosimetry 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2015-02-16
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: iba dosimetry compass 3.1 / 3.1a medical device manufacturer, iba dosimetry, has issued a field safety notice concerning compass 3.1 / 3.1a [catalogue number: cs10-100. manufacturing date: may 2014 (for version 3.1) and nov 2014 (for version 3.1a)]. the manufacturer found that dose reconstruction for dmlc plans from monaco or eclipse-11 when the jaws move or mlc leaves reverse during beam on was not scaled correctly. normally, during the measurement-based correction process employed by compass, a step called “delivery error scaling” is carried out in order to correct for an overall absolute dose difference level between measured and predicted responses. a scale factor derived from this difference in absolute output is averaged over all detector pixels. the error occurs as the “delivery error scaling” is not properly applied. the reconstructed dose becomes erroneous although the predicted response remains correct. the error occurs when compass is used to acquire measurement data and the evaluation is performed using reconstructed dose. if the predicted response is not evaluated together, the erroneously reconstructed dose may not be noticed. this could happen if the measurement shape is correct but the absolute level is wrong. the manufacturer will provide software update to correct this issue. according to the local supplier, the affected product is distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. 16 february 2015.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: IBA Dosimetry COMPASS 3.1 / 3.1a
  • Manufacturer

Manufacturer